Mann Eye Institute Expands Innovative EverTears Dry Eye Treatment After Extensive Evaluation
An industry leader in dry eye treatment has partnered with an innovative medical device start-up to deliver an effective dry eye treatment.
ATLANTA, GEORGIA, USA, April 19, 2022 /EINPresswire.com/ — Representatives of ThermaMEDx today announced that the Mann Eye Institute has partnered with the company to evaluate EverTears, the world’s first combination compress self-heating eyepiece and pre-moistened cleaning pad.
Carl Sweat, co-founder of ThermaMEDx, said EverTears is designed to provide a convenient and affordable over-the-counter dry eye solution that delivers the precise, controlled heat and eyelid cleansing found in many in-office treatments. EverTears is based on patented technology developed by ThermaMEDx co-founder, Dr. Michel Guillon, to not only relieve dry eye symptoms, but also help restore the eye’s natural tear film when used. in accordance with the instructions.
Mann Eye Institute is the premier provider of LASIK eye surgery, dry eye treatment, and general eye care in the greater Houston area and one of the largest private eye care practices in Texas.
Mann Eye Institute CEO and Executive Director, Dr. Dana Ondrias, explained that providing innovative eye care has long been a key part of the organization’s mission: “Just like our founder, Dr. Mike Mann, Being one of the first physicians in America to perform refractive surgery in 1981, our dedicated staff embraces innovative solutions that advance patient care. She added: “Our doctors and staff started giving the EverTears treatment to dry eye patients late last year and we were pleased with both the patient feedback and the improvement in their condition. underlying MGD.” Based on the test results, the Mann Eye Institute is expanding EverTears to additional Texas sites as the standard of care for dry eye treatment.
ThermaMEDx co-founder Ben Nobles was particularly excited about the expansion plans, saying “Texas is the epicenter of dry eye disease in America and innovative organizations like the Mann Eye Institute are at the forefront. -care to bring the latest technology to their patients.We are committed to supporting the implementation of EverTears as the best treatment for dry eye disease related to Meibomian Gland Dysfunction (MGD).
For more information, please visit thermamedx.com/about-us and https://thermamedx.com/insights-news/
ThermaMEDx was founded to bring Dr. Michel Guillon’s vision of harnessing thermal energy to provide an accessible and effective treatment for dry eyes and meibomian gland dysfunction. ThermaMEDx is a family business led by our Medical Board of renowned physicians whose mission is to improve patient outcomes by striving to provide the best treatment for dry eyes caused by Meibomian Gland Dysfunction (MGD) available. for home use.
3343 Peachtree Road NE
Atlanta, Georgia 30326
write to us here